Epic Sciences

Epic Sciences is a biotechnology company focused on developing novel diagnostics to guide precision medicine in cancer treatment. They specialize in liquid biopsy technology that analyzes circulating tumor cells (CTCs) and other biomarkers from blood samples to provide actionable insights for personalized therapy. Founded in 2008, the company has made significant strides with its proprietary No Cell Left Behind® technology, which captures and characterizes rare cells. Epic Sciences generates revenue through partnerships with pharmaceutical companies, clinical testing services, and licensing agreements. Understanding their innovative approach and collaboration with leading cancer centers can be crucial for a candidate.

Recent Posts by Epic Sciences

1-1 of 1